Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff

被引:45
|
作者
Schmidt, Simone B. [1 ]
Grueter, Ludwig [2 ]
Boltzmann, Melanie [1 ]
Rollnik, Jens D. [1 ]
机构
[1] Hannover Med Sch, Associated Inst, Inst Neurorehabil Res, BDH Clin Hessisch Oldendorf, Hessisch Oldendorf, Germany
[2] Nordlab, Hameln, Germany
来源
PLOS ONE | 2020年 / 15卷 / 06期
关键词
D O I
10.1371/journal.pone.0235417
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The SARS-CoV-2 pandemic threatens health care providers and society. For planning of treatment capacities, it is of major importance to obtain reliable information on infection and fatality rates of the novel coronavirus. A German community study, the so-called Heinsberg study, found a 5-fold higher infection rate (and thus a remarkably lower fatality rate) than the officially reported cases suggest. We were interested to examine the SARS-CoV-2-IgG antibody status among clinic staff of a large neurological center in Northern Germany. Blood samples and questionnaires (demographic data, medical history) were collected pseudonymously. In total, 406 out of 525 (77.3%) of our employees participated in the study. The infection rate among the staff was as high as 2.7%. Including drop-outs (missing questionnaire but test result available), the infection rate was even higher (2.9%). Only 36% of the positively tested employees did suffer from flu-like symptoms in 2020. None of the nurses-having closest and longest contact to patients-were found to be positive. Despite the fact that the infection rate among clinic staff may not be directly compared to the situation in the surrounding county (due to different testing procedures), one might hypothesize that the infection rate could be more than 30-fold higher than the number of officially reported cases for the county of Hameln-Pyrmont. The high rate of IgG-positive, asymptomatic healthcare workers might help to overcome fears in daily work.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Prevalence of IgG antibodies to SARS-CoV-2 among emergency department employees
    Madsen, Troy
    Levin, Nicholas
    Niehus, Karla
    Law, Karen
    Mayer, Jeanmarie
    Chapman, Matthew
    Johnson, Austin
    Hartsell, Stephen
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (12): : 2752 - 2752
  • [2] Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany
    Mksoud, Maria
    Ittermann, Till
    Holtfreter, Birte
    Soehnel, Andreas
    Soehnel, Carmen
    Welk, Alexander
    Ulm, Lena
    Becker, Karsten
    Huebner, Nils-Olaf
    Rau, Andrea
    Kindler, Stefan
    Kocher, Thomas
    CLINICAL ORAL INVESTIGATIONS, 2022, 26 (05) : 3965 - 3974
  • [3] Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany
    Maria Mksoud
    Till Ittermann
    Birte Holtfreter
    Andreas Söhnel
    Carmen Söhnel
    Alexander Welk
    Lena Ulm
    Karsten Becker
    Nils-Olaf Hübner
    Andrea Rau
    Stefan Kindler
    Thomas Kocher
    Clinical Oral Investigations, 2022, 26 : 3965 - 3974
  • [4] Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland
    Kasztelewicz, Beata
    Janiszewska, Katarzyna
    Burzynska, Julia
    Szydlowska, Emilia
    Migdal, Marek
    Dzierzanowska-Fangrat, Katarzyna
    PLOS ONE, 2021, 16 (04):
  • [5] Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
    Arteaga-Mueller, Giovanna Yazmin
    Olivo-Gutierrez, Mara
    Favela-Aragon, Karla Lizbeth
    Hernandez-Castillo, Paola Alejandra
    Esquivel-Gomez, Victor
    Camacho-Ortiz, Adrian
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (02) : 457 - 458
  • [6] Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
    Giovanna Yazmin Arteaga-Müller
    Mara Olivo-Gutierrez
    Karla Lizbeth Favela-Aragon
    Paola Alejandra Hernández-Castillo
    Victor Esquivel-Gomez
    Adrian Camacho-Ortiz
    International Urology and Nephrology, 2022, 54 : 457 - 458
  • [7] High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2
    Menezes, Ana M. B.
    Victora, Cesar G.
    Hartwig, Fernando P.
    Silveira, Mariangela F.
    Horta, Bernardo L.
    Barros, Aluisio J. D.
    Mesenburg, Marilia A.
    Wehrmeister, Fernando C.
    Pellanda, Lucia C.
    Dellagostin, Odir A.
    Struchiner, Claudio J.
    Burattini, Marcelo N.
    Barros, Fernando C.
    Hallal, Pedro C.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2
    Ana M. B. Menezes
    Cesar G. Victora
    Fernando P. Hartwig
    Mariângela F. Silveira
    Bernardo L. Horta
    Aluísio J. D. Barros
    Marilia A. Mesenburg
    Fernando C. Wehrmeister
    Lúcia C. Pellanda
    Odir A. Dellagostin
    Cláudio J. Struchiner
    Marcelo N. Burattini
    Fernando C. Barros
    Pedro C. Hallal
    Scientific Reports, 11
  • [9] Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual
    Li, Jin
    Zou, Li
    Li, Shaojie
    Zou, Ruogu
    Fang, Zhixiong
    Zhang, Pingan
    Li, Huijun
    Wang, Shanshan
    Ke, Dong
    Gao, Peng
    Jin, Cuicui
    Fang, Cong
    Zhou, Ji
    He, Ellen
    Skog, Sven
    VIRAL IMMUNOLOGY, 2023, 36 (03) : 153 - 162
  • [10] Prevalence of SARS-CoV-2 IgG/IgM antibodies among patients in Zakho City, Kurdistan, Iraq
    Saeed, Ali Yahya
    Assafi, Mahde Saleh
    Othman, Hemin Esmael
    Shukri, Hogir Mohammed
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2022, 16 (07): : 1126 - 1130